Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-17
2007-07-17
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S303000, C514S340000, C546S118000, C546S255000, C546S309000
Reexamination Certificate
active
10730495
ABSTRACT:
The invention provides novel pyridines, pharmaceutical compositions comprising such pyridines, and the use of such compositions in treating injured mammalian nerve tissue, including but not limited to an injured spinal cord. In one embodiment, the compounds, compositions, and methods of the instant invention treat a mammalian nerve tissue injury by restoring action potential or nerve impulse conduction through a nerve tissue lesion. Significantly, in vivo application of compounds of the instant invention established, on the basis of SSEP testing, that the compounds provide longer lasting effects at lower concentrations than comparable treatment with the known agent 4-aminopyridine (4 AP).
REFERENCES:
patent: 3428642 (1969-02-01), Debay et al.
patent: 3433873 (1969-03-01), Reinert et al.
patent: 3804844 (1974-04-01), Pews et al.
patent: 3929779 (1975-12-01), Bickel et al.
patent: 3995042 (1976-11-01), Yale et al.
patent: 4304911 (1981-12-01), Zeintz
patent: 5540938 (1996-07-01), Masterson et al.
patent: 5545648 (1996-08-01), Hansebout et al.
patent: 5700935 (1997-12-01), Takenishi et al.
patent: 5763463 (1998-06-01), Takefuji et al.
patent: 5817668 (1998-10-01), Reitz et al.
patent: 5849772 (1998-12-01), Choi et al.
patent: 5861309 (1999-01-01), Bard et al.
patent: 5880128 (1999-03-01), Doll et al.
patent: 5990109 (1999-11-01), Chen et al.
patent: 6200984 (2001-03-01), Reitz et al.
patent: 6265416 (2001-07-01), Bastian et al.
patent: 6372768 (2002-04-01), Lowe, III
patent: 6495550 (2002-12-01), McNaughton-Smith et al.
patent: 6632823 (2003-10-01), Vernier et al.
patent: 6680329 (2004-01-01), Altenburger et al.
patent: 6727254 (2004-04-01), Tulshian et al.
patent: 6737423 (2004-05-01), Heinelt et al.
patent: 2002/0045613 (2002-04-01), Pauls et al.
patent: 2002/0091265 (2002-07-01), Bos et al.
patent: 2003/0092698 (2003-05-01), Czekaj et al.
patent: 2004/0186133 (2004-09-01), Aranyl et al.
patent: 3-181462 (1991-08-01), None
patent: 01/07436 (2001-02-01), None
Tanga et al., “Syntheses of five potential, etc.” CA 127:161747 (1997).
Shimizu et al., Anticytokinin activity of, etc., CA 112:193716 (1990).
Kiriazis et al., “Reactions of 2-, 3-, and 4-(N-nitrosomethylamino)pyridine, etc.,” CA 112:138873 (1989).
Sakamoto et al., “Condensed heteroaromatic ring, etc.,” CA 108:75166 (1987).
Von Bebenburg et al., “Substituted polyaminopyridines” CA 93:95098 (1980).
Yakhontov et al., “Synthesis of isomeric, etc.,” CA 69:86786 (1968).
Imperial Chemical., “Herbicidal compositions” CA 68:59438 (1968).
Clark-Lewis et al., “Preparation of 3,4-diamino, etc.,” CA 57:23142 (1962).
Takahasi et al., “Pyridine derivatives, etc.,” CA 51:12837 (1957).
Chemical & Engineering News, Feb. 24, 2003, pp. 32-35.
Gutmann et al. “Phosphoric acid amides” CA 59:9108 (1963).
Hand et al. “Catalytic reduction . . . ” CA 84:74052 (1976).
Tadzhitdinov et al. “Phosphoric acid . . . ” CA 101:23604 (1984).
Gansel et al. “Distinct sites of action . . . ” CA 107:72640 (1987).
Greensmith et al. “Induction of transmitter release . . . ” CA 124:136369 (1996).
Shi et al. “Differential effects . . . ” CA 126:258964 (1997).
Bundgaard H. “Design of prodrugs” Elsevier, p. 27-33 (1985).
Stahl et al. “Targeting the central nervous system . . . ” Psychopharm. Bull. v.21(3) p. 657-662 (1985).
Pop et al. “Application of a brain targeting . . . ” pharm. Res. v.7(6) 658-664(1990).
Debay et al. “Carbamates . . . ” CA 69:106565 (1968).
Kano et al. “Effects of ketamine . . . ” CA 81:9924 (1974).
Demenge et al. “Indentification . . . ” CA 95:58741 (1981).
Liu et al. “Potent activation of . . . ” CA 142:254331 (2004).
Matondo, H. et al., “Kinetics of the Hydrolysis of the Potentially Pesticidal N-(4-Pyridyl)carbamates in Micellar Solution”,J. Agric. Food Chem., vol. 38, No. 4, pp. 1106-1109, (1990).
Matondo, H. et al., “Synthesis, Mechanism of Action, and Herbicidal Activity of New Aryl”,J. Agric. Food Chem., vol. 37, No. 1, pp. 169-172, (1989).
Borgens Richard B.
Byrn Stephen R.
Shi Riyi
Smith Daniel T.
Chang Celia
Faucett III Homer W.
Ice Miller
Purdue Research Foundation
Walsh Thomas A.
LandOfFree
Pyridines for treating injured mammalian nerve tissue does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridines for treating injured mammalian nerve tissue, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridines for treating injured mammalian nerve tissue will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3771407